Eric Shi, DPM
Podiatry · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shi’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$97,301
Medicare paid this office $97,301 for 355 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 164 | $23,162 | $80 |
| New patient visit (45+ min) | 107 | $15,756 | $147 |
| Return visit (30+ min) | 72 | $10,165 | $116 |
| New patient visit (30+ min) | 103 | $9,345 | $91 |
| Removal of fingernails or toenails, 6 or more nails | 81 | $6,127 | $41 |
See all 14 services
| Short return visit (20+ min) | 164 | $23,162 | $80 |
| New patient visit (45+ min) | 107 | $15,756 | $147 |
| Return visit (30+ min) | 72 | $10,165 | $116 |
| New patient visit (30+ min) | 103 | $9,345 | $91 |
| Removal of fingernails or toenails, 6 or more nails | 81 | $6,127 | $41 |
| Removal of skin and tissue, 20.0 sq cm or less | 19 | $5,584 | $133 |
| Removal of noncancer thickened skin growth, 2-4 growths | 28 | $3,862 | $76 |
| Permanent removal fingernail or toenail | 20 | $3,363 | $160 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 135 | $2,619 | $15 |
| Removal of noncancer thickened skin growth, 1 growth | 24 | $2,465 | $63 |
| Short return visit | 24 | $1,191 | $48 |
| Removal of fingernails or toenails, 1-5 nails | 12 | $533 | $33 |
| Placement of strapping to ankle or foot | 18 | $488 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $28 | None |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Removal of nail tissue | 203 | More than 74% of doctors who do this |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 55 | More than 79% of doctors who do this |
| Removal or shaving of skin growth | 72 | More than 82% of doctors who do this |
Who their Medicare patients are
355 Original Medicare patients in 2024. Average age 74 · Under 65 9% · 85 and older 14% · Women 62% · Also on Medicaid 24% · Health risk score 1.55. Above the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 72% · Diabetes 37% · Chronic kidney disease 30% · Depression 24% · Coronary heart disease 23% · Heart failure 20% · Atrial fibrillation 18% · Cancer 14% · COPD 13% · Stroke 11% · Dementia 9%.
The office billed $384,336, Medicare allowed $131,338 and paid $97,301; for 1,276 services of 51 kinds; $100 of it was for drugs given in the office and $97,201 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 355 | 1,276 | 74 | 1.55 | $384,336 | $97,301 |
| 2023 | 322 | 1,032 | 73 | 1.52 | $393,409 | $101,433 |
| 2022 | 274 | 878 | 75 | 1.59 | $301,429 | $80,069 |
| 2021 | 287 | 938 | 73 | 1.78 | $348,798 | $93,824 |
| 2020 | 203 | 671 | 73 | 1.99 | $257,497 | $62,039 |
| 2019 | 231 | 571 | 75 | 1.97 | $237,984 | $52,638 |
| 2018 | 114 | 228 | 75 | 1.55 | $93,946 | $20,972 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Short return visit (20+ min) | 184 | $27,160 | $83 |
| Return visit (30+ min) | 96 | $15,390 | $110 |
| New patient visit (45+ min) | 111 | $15,128 | $136 |
| Removal of skin and tissue, 20.0 sq cm or less | 18 | $5,926 | $132 |
| New patient visit (30+ min) | 57 | $5,867 | $103 |
| Removal of fingernails or toenails, 6 or more nails | 66 | $4,095 | $42 |
| Removal of noncancer thickened skin growth, 2-4 growths | 17 | $2,735 | $76 |
| Permanent removal fingernail or toenail | 15 | $2,625 | $146 |
| Removal of noncancer thickened skin growth, 1 growth | 16 | $1,751 | $73 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $15 | None |
2022: 8 services
| Short return visit (20+ min) | 127 | $17,325 | $78 |
| Return visit (30+ min) | 90 | $16,374 | $114 |
| New patient visit (45+ min) | 83 | $11,835 | $143 |
| Removal of fingernails or toenails, 6 or more nails | 82 | $5,197 | $40 |
| New patient visit (30+ min) | 55 | $4,956 | $90 |
| Removal of noncancer thickened skin growth, 2-4 growths | 16 | $2,899 | $78 |
| Removal of noncancer thickened skin growth, 1 growth | 14 | $1,605 | $67 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $26 | None |
2021: 11 services
| Short return visit (20+ min) | 104 | $15,354 | $83 |
| New patient visit (30+ min) | 136 | $12,917 | $95 |
| Return visit (30+ min) | 64 | $12,097 | $119 |
| Removal of skin and tissue, 20.0 sq cm or less | 18 | $8,907 | $125 |
| Removal of fingernails or toenails, 6 or more nails | 87 | $5,670 | $43 |
| New patient visit (45+ min) | 28 | $4,321 | $154 |
| Removal of noncancer thickened skin growth, 2-4 growths | 17 | $2,715 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,370 | $169 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,961 | $123 |
| Removal of noncancer thickened skin growth, 1 growth | 12 | $1,395 | $70 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $23 | None |
2020: 8 services
| Short return visit (20+ min) | 90 | $10,096 | $64 |
| New patient visit (30+ min) | 105 | $9,007 | $86 |
| Removal of skin and tissue, 20.0 sq cm or less | 16 | $5,616 | $122 |
| Return visit (30+ min) | 26 | $4,546 | $103 |
| Removal of fingernails or toenails, 6 or more nails | 65 | $3,879 | $41 |
| New patient visit (45+ min) | 14 | $2,155 | $154 |
| Removal of noncancer thickened skin growth, 2-4 growths | 17 | $1,711 | $68 |
| Removal of noncancer thickened skin growth, 1 growth | 14 | $1,107 | $55 |
2019: 8 services
| New patient visit (30+ min) | 63 | $6,157 | $98 |
| Short return visit (20+ min) | 55 | $5,038 | $65 |
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $4,830 | $121 |
| Removal of fingernails or toenails, 6 or more nails | 80 | $4,701 | $36 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,611 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,463 | $122 |
| Removal of noncancer thickened skin growth, 1 growth | 18 | $1,088 | $49 |
| Removal of noncancer thickened skin growth, 2-4 growths | 14 | $944 | $59 |
2018: 3 services
| Short return visit (20+ min) | 23 | $2,749 | $69 |
| Removal of fingernails or toenails, 6 or more nails | 39 | $2,204 | $44 |
| New patient visit (30+ min) | 13 | $1,314 | $101 |
Drugs they prescribed that Part D paid
$4,128
Pharmacies billed $4,128 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 9% of their Part D prescriptions (18 of 207) in 2024. Above the middle of the specialty; the typical podiatry clinician is at 5%.
206 generic and fewer than 11 brand-name prescriptions · $4,128 in drug cost · 24 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Terbinafine | 65 | $1,403 | $22 |
| Ciclopirox | 32 | $993 | $31 |
| Econazole Nitrate | 14 | $430 | $31 |
| Diclofenac | 14 | $309 | $22 |
| Cephalexin | 15 | $147 | $10 |
See all 7 drugs
| Terbinafine | 65 | $1,403 | $22 |
| Ciclopirox | 32 | $993 | $31 |
| Econazole Nitrate | 14 | $430 | $31 |
| Diclofenac | 14 | $309 | $22 |
| Cephalexin | 15 | $147 | $10 |
| Hydrocodone-Acetaminophen | 14 | $111 | $8 |
| Meloxicam | 21 | $41 | $2 |
Year by year
| 2024 | 207 | 127 | 9% (18) | None | $4,128 |
| 2023 | 176 | 94 | None | None | $3,790 |
| 2022 | 151 | 82 | 11% (16) | None | $2,868 |
| 2021 | 88 | 40 | None | 0% | $1,841 |
| 2020 | 66 | 38 | None | None | $1,508 |
| 2019 | 57 | 44 | 28% (16) | None | $2,060 |
| 2018 | 20 | 15 | None | None | $319 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 5 drugs
| Ciclopirox | 31 | $1,015 | $33 |
| Terbinafine | 57 | $901 | $16 |
| Diclofenac | 12 | $299 | $25 |
| Cephalexin | 13 | $146 | $11 |
| Meloxicam | 14 | $28 | $2 |
2022: 5 drugs
| Ciclopirox | 29 | $914 | $32 |
| Terbinafine | 45 | $536 | $12 |
| Econazole Nitrate | 11 | $386 | $35 |
| Hydrocodone-Acetaminophen | 15 | $118 | $8 |
| Ketoconazole | 11 | $109 | $10 |
2021: 2 drugs
| Ciclopirox | 25 | $808 | $32 |
| Cephalexin | 13 | $130 | $10 |
2020: 2 drugs
| Ciclopirox | 16 | $382 | $24 |
| Terbinafine | 14 | $181 | $13 |
Money from drug and device companies
$115 in 2022
| 2022 | 1 | 1 | None | $115 |
| 2020 | 2 | 11 | None | $1,211 |
| 2019 | 7 | 10 | None | $565 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Evolution Surgical | None | $115 | 1 payment
|
See the published payment
| Evolution Surgical | Meals · 2022-03-10 | None | $115 |
See earlier years (2020, 2019)
2020: $1,211
| Arthrex | None | $928 | 9 payments
|
| Evolution Surgical | None | $283 | 2 payments
|
2019: $565
| Stryker | Allowrap | $136 | 1 payment
|
| Evolution Surgical | None | $106 | 1 payment
|
| Medline Industries | None | $105 | 1 payment
|
| Medical Device Business Services | VA-Lcp Plates & Screws | $90 | 3 payments
|
| Osiris Therapeutics | Stravix | $77 | 1 payment
|
| Smith+Nephew | Stravix | $36 | 2 payments
|
| In2Bones USA | Alloaid Allograft | $15 | 1 payment
|
Professional record
- NPI
- 1427435718
- Licence
- CA E5400
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X); Student in a training program (390200000X)
- Mailing address
- 2350 W El Camino Real Fl 2, Mountain View, CA, 94040
- NPI first listed
- 2015-05-06
- NPI last updated
- 2018-07-09
This is when the NPI record was last certified, not a medical board exam.